On day one we heard an update concerning BG-12 for MS. I'm really excited to hear more and more about this medication because it's something I'm looking forward to as a treatment for my MS.
There is so much going on in the world of MS it's hard to keep up at times.
There are so many studies in the MS Pipeline, it's unbelievable! And from what I have seen in the exhibit center... A lot of companies and organizations are focusing on the Quality of Life for those living with MS.
So, what do you want to hear more about?? Are there things that you feel should be addressed in the world of MS that isn't being addressed now.
I know another big subject I've seen is patient adherence.... We all know it's a pain to take those medications... But are we taking those medications as directed??
Some other things to look forward to are the studies of medications for those with progressive forms of MS!
As you've seen or heard in the past from previous conferences we have covered, Avonex now has not only the Avonex pen which I had a vision last year at ECTRIMS in Amsterdam, but also the titration kit... This titration kit into help ease you onto the medication and studies have shown a reduction in flu-like symptoms for those starting Avonex on the titration kit.
During this meeting there will be a discussion in a phase 3 trial on copaxone taken 3 times a week compared to placebo.
Another thing I hope we hear more about is Alemtuzumab aka Campath as a treatment for MS.
I also hope to learn more about what is being researched as far as symptom management.
Keep sending in your questions to QandA@msworld.org, I'm writing them all down and will try my hardest to get them answered.
I will give another update soon, it's time to continue with Day Two coverage.
No comments:
Post a Comment